Factors associated with secondary thoracotomy for hemostasis following lung surgery: a retrospective analysis [0.03%]
术后二次开胸止血的相关因素分析：一项回顾性研究
Junwei Xie,Hongliang Wang,Tianci Han et al.
Junwei Xie et al.
Purpose: This study aimed to systematically investigate the causes and management of secondary thoracotomy for hemostasis following lung cancer surgery. Although infrequent, secondary thoracotomy can lead to prolonged hos...
The double role of GABAergic system in systemic tumors: an updated review [0.03%]
系统肿瘤中γ-氨基丁酸能系统的双重作用：最新综述
Xueyang Yang,Qianhe Zu,Luxuan Wang et al.
Xueyang Yang et al.
The GABAergic system is the main inhibitory nervous system. In addition, GABA has been reported to affect tumor growth and its expression differs between tumor tissue and normal tissue. However, the impact of GABAergic system on tumor progr...
Case Report: Malignant perivascular epithelioid cell tumor with aggressive mediastinal invasion and pulmonary metastasis [0.03%]
恶性血管周上皮样细胞肿瘤伴主动脉及肺转移侵袭性纵隔侵犯一例
Daniel F Leach rd,Srivikram Margam S,Marissa Foster et al.
Daniel F Leach rd et al.
Perivascular epithelioid cell tumors (PEComas) are rare, typically benign soft tissue tumors that can develop at various anatomic sites. Malignant PEComas are rarer entities but may present aggressively with metastasis to the lungs or local...
High carbohydrate antigen 19-9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy [0.03%]
根治性膀胱切除术后高碳水化合物抗原19-9水平提示膀胱癌预后不良
Sang Won So,Jang Hee Han,Hyeong Dong Yuk et al.
Sang Won So et al.
Introduction: Our team previously reported that elevated carbohydrate antigen (CA) 19-9 levels are associated with a worse prognosis in upper tract urothelial carcinoma (UTUC). Several studies have reported a correlation ...
Hybrid feature fusion in cervical cancer cytology: a novel dual-module approach framework for lesion detection and classification using radiomics, deep learning, and reproducibility [0.03%]
基于影像组学、深度学习和可重复性的宫颈癌液基细胞学双模块混合特征融合框架的研究
Shurong Niu,Lili Zhang,Lina Wang et al.
Shurong Niu et al.
Objective: Cervical cancer screening through cytology remains the gold standard for early detection, but manual analysis is time-consuming, labor-intensive, and prone to inter-observer variability. This study proposes an ...
Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review [0.03%]
奥比妥珠单抗联合苯达莫司汀治疗毛细胞白血病变异型一例并文献复习
Junjun Bai,Yi Zhang,Kangqi Lv et al.
Junjun Bai et al.
Hairy cell leukemia variant (HCL-v) is a rare and more aggressive subtype of B-cell leukemia. While it shares certain clinical features with classical hairy cell leukemia (HCL-c), HCL-v typically follows a more malignant course and responds...
2-Deoxy-D-Glucose and ES-936 sensitize cancer- but not normal cells to both low- and high LET irradiation [0.03%]
2-脱氧-D-葡萄糖和ES-936使癌细胞而不是正常细胞对低LET和高LET辐射敏感
Katja Kratz,Henrieke Förster,Kira Vogel et al.
Katja Kratz et al.
Introduction: Metabolic differences of normal- and cancer cells represent an important target for the development of novel cancer treatment strategies. Given that radiotherapy constitutes one of the primary treatment moda...
Comparative evaluation of transmediastinal and minimally invasive McKeown esophagectomy for esophageal cancer: perioperative and oncologic outcomes [0.03%]
食管癌的经胸和微创McKeown食管切除术的围手术期和肿瘤学结果的比较评估
Zhichao Ni,Zigui Zhu,Xin Shi et al.
Zhichao Ni et al.
Background: Esophageal squamous cell carcinoma remains a major health burden in China, where surgical resection is the mainstay of curative therapy. The conventional minimally invasive McKeown esophagectomy (MIE-McKeown),...
Adverse events of pexidartinib for the treatment of TGCT: a real-world disproportionality analysis using FDA Adverse Event Reporting System database [0.03%]
基于FDA不良事件数据库的佩西达替尼治疗TGCT不良反应的 disproportionality 分析
Yu Lin,Xinlei Zheng,Li Lin et al.
Yu Lin et al.
Introduction: Pexidartinib, an oral selective colony-stimulating factor 1 receptor (CSF1R) inhibitor, is the only systemic therapy approved by the U.S. Food and Drug Administration (FDA) for tenosynovial giant cell tumor ...
Integrating radiomics, artificial intelligence, and molecular signatures in bone and soft tissue tumors: advances in diagnosis and prognostication [0.03%]
放射组学、人工智能和分子标志物在骨与软组织肿瘤中的应用：诊断及预后评估的进展
Guochao Li,Peipei Feng,Yayun Lin et al.
Guochao Li et al.
This systematic review evaluates the integration of radiomics, artificial intelligence (AI), and molecular signatures for diagnosing and prognosticating bone and soft tissue tumors (BSTTs). Following PRISMA 2020 guidelines, we analyzed 24 s...